Synthesis and In Situ Studies of New Porphyrin–Curcumin Analog Conjugates for Photodynamic Cancer Therapy

ABSTRACT Photodynamic therapy (PDT) has attracted significant attention as an alternative approach to traditional cancer therapies such as radiotherapy, chemotherapy, and surgery. In this work, the synthesis and photophysical properties of conjugates ( 1 – 4 ) of tetraphenylporphyrin and curcumin analogs were prepared and studied as candidates for PDT. The porphyrin components were shown to have fluorescence quantum yields (Φ FL ) in the 0.12–0.15 range, singlet oxygen quantum yields (Φ ∆ ) of 0.33–0.66, and reasonable solubilities in a 1:9 solution of DMSO/water. All four compounds were tested against pancreatic ductal adenocarcinoma (PDAC, AsPC‐1) and lung cancer (A549) cell lines using resazurin assays and FACS and flow cytometry analysis and exhibited little to no dark cytotoxicity (cellular viabilities ranging from 90% to 100%), whereas high cytotoxicity was observed upon irradiation at 640 nm (ranging from 58% to 67% for AsPC‐1 and 54%–69% for A549). Fluorescence imaging indicated significant uptake of 1 – 4 in the mitochondria. The significant cytotoxicity of 1 – 4 is therefore attributed to their accumulation in tumor cells followed by singlet oxygen generation leading to cell death.

Authors

Institutions

Publication Details

Journal
Journal of Physical Organic Chemistry
Published
2026-11-12
DOI
https://doi.org/10.1002/poc.70119
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis and In Situ Studies of New Porphyrin–Curcumin Analog Conjugates for Photodynamic Cancer Therapy

David A. Modarelli, Leah P. Shriver, Mostafa A. Abdelaziz, Adam J. Lampner
Journal of Physical Organic Chemistry
Photodynamic Therapy Research Studies
article

Synthesis and In Situ Studies of New Porphyrin–Curcumin Analog Conjugates for Photodynamic Cancer Therapy

David A. Modarelli, Leah P. Shriver, Mostafa A. Abdelaziz, Adam J. Lampner
article en

Abstract

ABSTRACT Photodynamic therapy (PDT) has attracted significant attention as an alternative approach to traditional cancer therapies such as radiotherapy, chemotherapy, and surgery. In this work, the synthesis and photophysical properties of conjugates ( 1 – 4 ) of tetraphenylporphyrin and curcumin analogs were prepared and studied as candidates for PDT. The porphyrin components were shown to have fluorescence quantum yields (Φ FL ) in the 0.12–0.15 range, singlet oxygen quantum yields (Φ ∆ ) of 0.33–0.66, and reasonable solubilities in a 1:9 solution of DMSO/water. All four compounds were tested against pancreatic ductal adenocarcinoma (PDAC, AsPC‐1) and lung cancer (A549) cell lines using resazurin assays and FACS and flow cytometry analysis and exhibited little to no dark cytotoxicity (cellular viabilities ranging from 90% to 100%), whereas high cytotoxicity was observed upon irradiation at 640 nm (ranging from 58% to 67% for AsPC‐1 and 54%–69% for A549). Fluorescence imaging indicated significant uptake of 1 – 4 in the mitochondria. The significant cytotoxicity of 1 – 4 is therefore attributed to their accumulation in tumor cells followed by singlet oxygen generation leading to cell death.

Journal of Physical Organic ChemistryVol. 39(12)
University of Akron (US), Washington University in St. Louis (US)
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon